This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Marvin Moser, MD; M. Donald Blaufox, MD, PhD; Edward Freis, MD; Raymond W. Gifford, Jr, MD; Walter Kirkendall, MD; Herbert Langford, MD; Alvin Shapiro, MD; Sheldon Sheps, MD

JAMA. 1991;265(4):498-500.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE WIDESPREAD publicity and public response to a recent study by Pollare et al,¹ who described changes in serum cholesterol levels and glucose metabolism with hydrochlorothiazide compared with an angiotensin converting enzyme inhibitor, captopril, serve to highlight the impact of the media and pharmaceutical industry on the practice of medicine. Patients' reactions were predictable following a front-page story in the New York Times, articles in more than 200 newspapers, and national television coverage. Many patients expressed concerns about their treatment despite the fact that their hypertension may have been well controlled by diuretic therapy for many years. As physicians who have had a long-standing interest and commitment to improving the treatment of hypertension, we are concerned about the manner in which the results of this study were disseminated to the public and to the medical profession. The methods used represent a clear attempt to market a product directly to . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Medicine as Yale University School of Medicine, New Haven, Conn (Dr Moser); Albert Einstein College of Medicine, New York, NY (Dr Blaufox); Veterans Administration, Washington, DC (Dr Freis); Cleveland (Ohio) Clinic Foundation (Dr Gifford); The University of Texas Health Science Center at Houston (Dr Kirkendall); The University of Mississippi School of Medicine, Jackson (Dr Langford); University of Pittsburgh (Pa) School of Medicine (Dr Shapiro); and the Mayo Clinic Foundation, Rochester, Minn (Dr Sheps).

Footnotes
Drs Moser, Gifford, and Sheps are members of the National High Blood Pressure Coordinating Committee of the National Heart, Lung, and Blood Institute, Bethesda, Md.

Reprint requests to Davis Avenue Medical Center, 33 Davis Ave, White Plains, NY 10605 (Dr Moser).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?